XML 37 R24.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Segment Information (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2018
Segment Reporting [Abstract] |
Sales and Other Financial Information by Business Segment |
| Three Months |  | Nine Months
| 2018 | 2017 |  | 2018 | 2017
Orthopaedics | $ | 1,171 |  | $ | 1,132 |  |  | $ | 3,615 |  | $ | 3,408 |
MedSurg | 1,443 |  | 1,336 |  |  | 4,325 |  | 3,977 |
Neurotechnology and Spine | 628 |  | 538 |  |  | 1,865 |  | 1,588 |
Net sales | $ | 3,242 |  | $ | 3,006 |  |  | $ | 9,805 |  | $ | 8,973 |
Orthopaedics | $ | 397 |  | $ | 390 |  |  | $ | 1,263 |  | $ | 1,178 |
MedSurg | 341 |  | 272 |  |  | 968 |  | 841 |
Neurotechnology and Spine | 173 |  | 157 |  |  | 532 |  | 446 |
Segment operating income | $ | 911 |  | $ | 819 |  |  | $ | 2,763 |  | $ | 2,465 |
Items not allocated to segments: |  |  |  |  |
Corporate and other | (104 | ) | (89 | ) |  | (291 | ) | (265 | )
Acquisition and integration-related charges | (8 | ) | (11 | ) |  | (49 | ) | (29 | )
Amortization of purchased intangible assets | (112 | ) | (92 | ) |  | (324 | ) | (275 | )
Restructuring-related and other charges | (39 | ) | (36 | ) |  | (124 | ) | (119 | )
European Medical Devices Regulation | (2 | ) | — |  |  | (5 | ) | — |
Rejuvenate and other recall-related matters | (4 | ) | (66 | ) |  | (10 | ) | (164 | )
Regulatory and legal matters | (66 | ) | — |  |  | (121 | ) | (30 | )
Consolidated operating income | $ | 576 |  | $ | 525 |  |  | $ | 1,839 |  | $ | 1,583 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration